The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study.

Journal Article (Journal Article)

Anorexia nervosa (AN) is a serious, potentially life-threatening disorder characterized by severe weight loss, dysregulated eating, and often excessive exercise. While psychiatric illnesses such as depression are associated with increased levels of pro-inflammatory mediators, evidence for such disturbances in patients with AN has been less clear. In an exploratory study of possible disturbances in immune responses in AN, we assayed a panel of cytokines and chemokines in the blood of patients undergoing inpatient treatment, testing the hypothesis that metabolic disturbances in this disease would lead to a pattern of immune disturbances distinct from that of other psychiatric diseases. For this purpose, we evaluated patients by the Beck Depression Inventory-II (BDI-II) and the Eating Disorders Examination-Questionnaire and assessed cytokines and chemokines by enzyme-linked immunosorbent assays. Patients reported a moderate level of depression (mean BDI-II = 22.6) but exhibited few immunologic abnormalities of the kind associated with major depressive disorder [e.g., increased interleukin (IL)-6]; RANTES showed the most frequent elevations and was increased in 4 of the patients studied. Together, these findings suggest that features of AN such as loss of adipose tissue and excessive exercise may attenuate cytokine production and thus modulate the experience of illness that impacts on core features of disease.

Full Text

Duke Authors

Cited Authors

  • Pisetsky, DS; Trace, SE; Brownley, KA; Hamer, RM; Zucker, NL; Roux-Lombard, P; Dayer, J-M; Bulik, CM

Published Date

  • September 2014

Published In

Volume / Issue

  • 69 / 1

Start / End Page

  • 110 - 115

PubMed ID

  • 25022969

Pubmed Central ID

  • PMC4411080

Electronic International Standard Serial Number (EISSN)

  • 1096-0023

Digital Object Identifier (DOI)

  • 10.1016/j.cyto.2014.05.018


  • eng

Conference Location

  • England